{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T14:26:34Z","timestamp":1777818394109,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the clinical medicine +X scientific research project of the Affiliated Hospital of Qingdao University","award":["QDFY+X2024220"],"award-info":[{"award-number":["QDFY+X2024220"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01865-0","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T14:52:56Z","timestamp":1754664776000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CT-based radiomics model for noninvasive prediction of progression-free survival in high-grade serous ovarian carcinoma: a multicenter study incorporating preoperative and postoperative clinical factors"],"prefix":"10.1186","volume":"25","author":[{"given":"Xinping","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinwen","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengjian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"issue":"Suppl 10","key":"1865_CR1","doi-asserted-by":"publisher","first-page":"x16","DOI":"10.1093\/annonc\/mdt463","volume":"24","author":"RJ Kurman","year":"2013","unstructured":"Kurman RJ. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. Ann Oncol. 2013;24(Suppl 10):x16\u201321.","journal-title":"Ann Oncol"},{"key":"1865_CR2","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY. Ovarian cancer. Nat Rev Dis Primers. 2016;2:16061.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"1865_CR3","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/ijms20040952","volume":"20","author":"MA Lisio","year":"2019","unstructured":"Lisio MA, Fu L, Goyeneche A, Gao ZH, Telleria C. High-Grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints. Int J Mol Sci. 2019;20(4):952.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1865_CR4","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1136\/ijgc-2023-004872","volume":"34","author":"B Bouvarel","year":"2024","unstructured":"Bouvarel B, Colomban O, Frenel JS, Loaec C, Bourgin C, Berton D, et al. Clinical impact of CA-125 elimination rate constant K (KELIM) on surgical strategy in advanced serous ovarian cancer patients. Int J Gynecol Cancer. 2024;34(4):574\u201380.","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"1865_CR5","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.2214\/AJR.15.15199","volume":"206","author":"S Javadi","year":"2016","unstructured":"Javadi S, Ganeshan DM, Qayyum A, Iyer RB, Bhosale P. Ovarian cancer, the revised FIGO staging system, and the role of imaging. AJR Am J Roentgenol. 2016;206(6):1351\u201360.","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"1865_CR6","doi-asserted-by":"publisher","first-page":"101146","DOI":"10.1016\/j.xcrm.2023.101146","volume":"4","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Zhou K, Sun Z, Wang H, Xie J, Zhang T, et al. Non-invasive tumor microenvironment evaluation and treatment response prediction in gastric cancer using deep learning radiomics. Cell Rep Med. 2023;4(8):101146.","journal-title":"Cell Rep Med"},{"issue":"10","key":"1865_CR7","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.diii.2018.11.007","volume":"100","author":"S Nougaret","year":"2019","unstructured":"Nougaret S, Tardieu M, Vargas HA, Reinhold C, Vande Perre S, Bonanno N, et al. Ovarian cancer: an update on imaging in the era of radiomics. Diagn Interv Imaging. 2019;100(10):647\u201355.","journal-title":"Diagn Interv Imaging"},{"issue":"1","key":"1865_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s40001-023-01561-1","volume":"28","author":"J Chen","year":"2023","unstructured":"Chen J, Yang F, Liu C, Pan X, He Z, Fu D, et al. Diagnostic value of a CT-based radiomics nomogram for discrimination of benign and early stage malignant ovarian tumors. Eur J Med Res. 2023;28(1):609.","journal-title":"Eur J Med Res"},{"issue":"6","key":"1865_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13244-012-0196-6","volume":"3","author":"F Davnall","year":"2012","unstructured":"Davnall F, Yip CS, Ljungqvist G, Selmi M, Ng F, Sanghera B, et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging. 2012;3(6):573\u201389.","journal-title":"Insights Imaging"},{"issue":"1","key":"1865_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41698-024-00666-y","volume":"8","author":"C You","year":"2024","unstructured":"You C, Su GH, Zhang X, Xiao Y, Zheng RC, Sun SY, et al. Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection. NPJ Precis Oncol. 2024;8(1):193.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"1865_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13244-023-01415-8","volume":"14","author":"B Kocak","year":"2023","unstructured":"Kocak B, Baessler B, Bakas S, Cuocolo R, Fedorov A, Maier-Hein L, et al. CheckList for evaluation of radiomics research (CLEAR): a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII. Insights Imaging. 2023;14(1):75.","journal-title":"Insights Imaging"},{"issue":"1","key":"1865_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13244-023-01572-w","volume":"15","author":"B Kocak","year":"2024","unstructured":"Kocak B, Akinci D\u2019Antonoli T, Mercaldo N, Alberich-Bayarri A, Baessler B, Ambrosini I, et al. METhodological radiomics score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII. Insights Imaging. 2024;15(1):8.","journal-title":"Insights Imaging"},{"key":"1865_CR13","doi-asserted-by":"publisher","first-page":"1559398","DOI":"10.3389\/fonc.2025.1559398","volume":"15","author":"X Yu","year":"2025","unstructured":"Yu X, Zou Y, Wang C, Wang L, Jiao J, Yu H, et al. Habitat-based radiomics for preoperative differentiation between early-stage serous borderline ovarian tumors and malignant ovarian tumors. Front Oncol. 2025;15:1559398.","journal-title":"Front Oncol"},{"key":"1865_CR14","doi-asserted-by":"publisher","first-page":"m441","DOI":"10.1136\/bmj.m441","volume":"368","author":"RD Riley","year":"2020","unstructured":"Riley RD, Ensor J, Snell KIE, Harrell FE Jr, Martin GP, Reitsma JB, et al. Calculating the sample size required for developing a clinical prediction model. BMJ. 2020;368:m441.","journal-title":"BMJ"},{"issue":"2","key":"1865_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/IGC.0b013e3182070f17","volume":"21","author":"GJ Rustin","year":"2011","unstructured":"Rustin GJ, Vergote I, Eisenhauer E, Pujade-Lauraine E, Quinn M, Thigpen T, et al. Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the gynecological cancer intergroup (GCIG). Int J Gynecol Cancer. 2011;21(2):19\u2013423.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"1865_CR16","doi-asserted-by":"publisher","first-page":"e1918939","DOI":"10.1001\/jamanetworkopen.2019.18939","volume":"3","author":"X Paoletti","year":"2020","unstructured":"Paoletti X, Lewsley LA, Daniele G, Cook A, Yanaihara N, Tinker A, et al. Assessment of Progression-Free survival as a surrogate end point of overall survival in First-Line treatment of ovarian cancer: A systematic review and Meta-analysis. JAMA Netw Open. 2020;3(1):e1918939.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"1865_CR17","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1097\/IGC.0b013e31821a3726","volume":"21","author":"X Chang","year":"2011","unstructured":"Chang X, Ye X, Dong L, Cheng H, Cheng Y, Zhu L, et al. Human epididymis protein 4 (HE4) as a serum tumor biomarker in patients with ovarian carcinoma. Int J Gynecol Cancer. 2011;21(5):852\u20138.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"1865_CR18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1148\/radiol.2017161697","volume":"285","author":"S Nougaret","year":"2017","unstructured":"Nougaret S, Lakhman Y, G\u00f6nen M, Goldman DA, Micc\u00f2 M, D\u2019Anastasi M, et al. High-Grade serous ovarian cancer: associations between BRCA mutation status, CT imaging phenotypes, and clinical outcomes. Radiology. 2017;285(2):472\u201381.","journal-title":"Radiology"},{"issue":"1","key":"1865_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13244-024-01855-w","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Wei M, Chen Y, Jia J, Zhang Y, Dai Y, et al. Intratumoral and peritumoral MRI-based radiomics for predicting extrapelvic peritoneal metastasis in epithelial ovarian cancer. Insights Imaging. 2024;15(1):281.","journal-title":"Insights Imaging"},{"issue":"3","key":"1865_CR20","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2214\/AJR.20.23195","volume":"217","author":"HM Li","year":"2021","unstructured":"Li HM, Gong J, Li RM, Xiao ZB, Qiang JW, Peng WJ, et al. Development of MRI-Based radiomics model to predict the risk of recurrence in patients with advanced High-Grade serous ovarian carcinoma. AJR Am J Roentgenol. 2021;217(3):664\u201375.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"1865_CR21","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1186\/s12885-024-13207-4","volume":"24","author":"XH Wu","year":"2024","unstructured":"Wu XH, Ke ZB, Chen ZJ, Liu WQ, Xue YT, Chen SH, et al. Periprostatic fat magnetic resonance imaging based radiomics nomogram for predicting biochemical recurrence-free survival in patients with non-metastatic prostate cancer after radical prostatectomy. BMC Cancer. 2024;24(1):1459.","journal-title":"BMC Cancer"},{"issue":"5","key":"1865_CR22","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1245\/s10434-011-1943-5","volume":"19","author":"SY Kong","year":"2012","unstructured":"Kong SY, Han MH, Yoo HJ, Hwang JH, Lim MC, Seo SS, et al. Serum HE4 level is an independent prognostic factor in epithelial ovarian cancer. Ann Surg Oncol. 2012;19(5):1707\u201312.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1865_CR23","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ygyno.2006.07.027","volume":"104","author":"MM Juretzka","year":"2007","unstructured":"Juretzka MM, Barakat RR, Chi DS, Iasonos A, Dupont J, Abu-Rustum NR, et al. CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy. Gynecol Oncol. 2007;104(1):176\u201380.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1865_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","volume":"19","author":"DK Armstrong","year":"2021","unstructured":"Armstrong DK, Alvarez RD, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, et al. Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(2):191\u2013226.","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"1865_CR25","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.3390\/cancers13123015","volume":"13","author":"G La Saint-Esteven","year":"2021","unstructured":"La Saint-Esteven G, Vuong A, Tschanz D, van Timmeren F, Dal Bello JE, Waller R. Systematic review on the association of radiomics with tumor biological endpoints. Cancers (Basel). 2021;13(12):3015.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1865_CR26","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s10278-022-00770-0","volume":"36","author":"FH Tang","year":"2023","unstructured":"Tang FH, Xue C, Law MY, Wong CY, Cho TH, Lai CK. Prognostic prediction of cancer based on radiomics features of diagnostic imaging: the performance of machine learning strategies. J Digit Imaging. 2023;36(3):1081\u201390.","journal-title":"J Digit Imaging"},{"issue":"1064","key":"1865_CR27","doi-asserted-by":"publisher","first-page":"20160242","DOI":"10.1259\/bjr.20160242","volume":"89","author":"D Molina","year":"2016","unstructured":"Molina D, P\u00e9rez-Beteta J, Luque B, Arregui E, Calvo M, Borr\u00e1s JM, et al. Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival. Br J Radiol. 2016;89(1064):20160242.","journal-title":"Br J Radiol"},{"issue":"1","key":"1865_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13058-022-01516-0","volume":"24","author":"X Wang","year":"2022","unstructured":"Wang X, Xie T, Luo J, Zhou Z, Yu X, Guo X. Radiomics predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment. Breast Cancer Res. 2022;24(1):20.","journal-title":"Breast Cancer Res"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01865-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01865-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01865-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T19:40:53Z","timestamp":1757360453000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01865-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1865"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01865-0","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Affiliated Hospital of Qingdao University and Yantai Yeda Hospital approved this study and waived informed consent. Our study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"320"}}